147 related articles for article (PubMed ID: 35781406)
1. A Multicentre Clinical Study of Sarcoma Personalised Treatment Using Patient-Derived Tumour Xenografts.
Xu H; Zheng H; Zhang Q; Song H; Wang Q; Xiao J; Dong Y; Shen Z; Wang S; Wu S; Wei Y; Lu W; Zhu Y; Niu X
Clin Oncol (R Coll Radiol); 2023 Jan; 35(1):e48-e59. PubMed ID: 35781406
[TBL] [Abstract][Full Text] [Related]
2. A multicenter clinical study: personalized medication for advanced gastrointestinal carcinomas with the guidance of patient-derived tumor xenograft (PDTX).
Cheng Y; Qin SK; Li J; Dai GH; Shen BY; Ying JE; Ba Y; Liang H; Wang XB; Xu Y; Zhou L; Ding KF; Qin YR; Yang SJ; Guan WX; Zheng H; Wang Q; Song H; Zhu YP
J Cancer Res Clin Oncol; 2022 Mar; 148(3):673-684. PubMed ID: 33864522
[TBL] [Abstract][Full Text] [Related]
3. Plocabulin, a Novel Tubulin Inhibitor, Has Potent Antitumour Activity in Patient-Derived Xenograft Models of Soft Tissue Sarcoma.
Wang Y; Wozniak A; Cornillie J; Avilés P; Debiec-Rychter M; Sciot R; Schöffski P
Int J Mol Sci; 2022 Jul; 23(13):. PubMed ID: 35806460
[TBL] [Abstract][Full Text] [Related]
4. Patient-derived tumour xenografts for breast cancer drug discovery.
Cassidy JW; Batra AS; Greenwood W; Bruna A
Endocr Relat Cancer; 2016 Dec; 23(12):T259-T270. PubMed ID: 27702751
[TBL] [Abstract][Full Text] [Related]
5. Kinomic profiling of tumour xenografts derived from patients with non-small cell lung cancer confirms their fidelity and reveals potentially actionable pathways.
Tabbò F; Guerrera F; van den Berg A; Gaudiano M; Maletta F; Bessone L; Nottegar A; Costardi L; de Wijn R; Ruijtenbeek R; Delsedime L; Sapino A; Ruffini E; Hilhorst R; Inghirami G
Eur J Cancer; 2021 Feb; 144():17-30. PubMed ID: 33316635
[TBL] [Abstract][Full Text] [Related]
6. Establishment of patient-derived tumor xenograft (PDTX) models using samples from CT-guided percutaneous biopsy.
Zhuang YP; Zhu YP; Wang HY; Sun L; Zhang J; Hao YP; Wang L
Braz J Med Biol Res; 2017 May; 50(6):e6000. PubMed ID: 28538836
[TBL] [Abstract][Full Text] [Related]
7. Comprehensive establishment and characterization of orthoxenograft mouse models of malignant peripheral nerve sheath tumors for personalized medicine.
Castellsagué J; Gel B; Fernández-Rodríguez J; Llatjós R; Blanco I; Benavente Y; Pérez-Sidelnikova D; García-Del Muro J; Viñals JM; Vidal A; Valdés-Mas R; Terribas E; López-Doriga A; Pujana MA; Capellá G; Puente XS; Serra E; Villanueva A; Lázaro C
EMBO Mol Med; 2015 May; 7(5):608-27. PubMed ID: 25810463
[TBL] [Abstract][Full Text] [Related]
8. Patient-derived xenografts for individualized care in advanced sarcoma.
Stebbing J; Paz K; Schwartz GK; Wexler LH; Maki R; Pollock RE; Morris R; Cohen R; Shankar A; Blackman G; Harding V; Vasquez D; Krell J; Zacharoulis S; Ciznadija D; Katz A; Sidransky D
Cancer; 2014 Jul; 120(13):2006-15. PubMed ID: 24705963
[TBL] [Abstract][Full Text] [Related]
9. Novel patient-derived xenograft and cell line models for therapeutic testing of pediatric liver cancer.
Bissig-Choisat B; Kettlun-Leyton C; Legras XD; Zorman B; Barzi M; Chen LL; Amin MD; Huang YH; Pautler RG; Hampton OA; Prakash MM; Yang D; Borowiak M; Muzny D; Doddapaneni HV; Hu J; Shi Y; Gaber MW; Hicks MJ; Thompson PA; Lu Y; Mills GB; Finegold M; Goss JA; Parsons DW; Vasudevan SA; Sumazin P; López-Terrada D; Bissig KD
J Hepatol; 2016 Aug; 65(2):325-33. PubMed ID: 27117591
[TBL] [Abstract][Full Text] [Related]
10. Establishment and Characterization of Histologically and Molecularly Stable Soft-tissue Sarcoma Xenograft Models for Biological Studies and Preclinical Drug Testing.
Cornillie J; Wozniak A; Li H; Wang Y; Boeckx B; Gebreyohannes YK; Wellens J; Vanleeuw U; Hompes D; Stas M; Sinnaeve F; Wafa H; Lambrechts D; Debiec-Rychter M; Sciot R; Schöffski P
Mol Cancer Ther; 2019 Jun; 18(6):1168-1178. PubMed ID: 30962320
[TBL] [Abstract][Full Text] [Related]
11. Assessment of Predictive Biomarkers of the Response to Pazopanib Based on an Integrative Analysis of High-grade Soft-tissue Sarcomas: Analysis of a Tumor Sample from a Responder and Patients with Other Soft-tissue Sarcomas.
Suehara Y; Kohsaka S; Yamaguchi S; Hayashi T; Kurihara T; Sano K; Sasa K; Akaike K; Ueno T; Kojima S; Ikegami M; Mizuno S; Okubo T; Kim Y; Kaneko K; Saito T; Kato S; Mano H
Clin Orthop Relat Res; 2020 Nov; 478(11):2461-2476. PubMed ID: 32567826
[TBL] [Abstract][Full Text] [Related]
12. Establishment of Patient-Derived Tumor Xenograft Models of High-Risk Endometrial Cancer.
Zhu M; Jia N; Nie Y; Chen J; Jiang Y; Lv T; Li Y; Yao L; Feng W
Int J Gynecol Cancer; 2018 Nov; 28(9):1812-1820. PubMed ID: 30358704
[TBL] [Abstract][Full Text] [Related]
13. Addressing Modern Diagnostic Pathology for Patient-Derived Soft Tissue Sarcosphere Models in the Era of Functional Precision Oncology.
Chen Y; Herzog M; Pliego-Mendieta A; Bühler MM; Harnisch KJ; Haberecker M; Arnold F; Planas-Paz L; Pauli C
Lab Invest; 2023 Apr; 103(4):100039. PubMed ID: 36870294
[TBL] [Abstract][Full Text] [Related]
14. [Advances in Patient Derived Tumor Xenograft (PDTX) Model from Lung Cancer].
Qin B; Jiao X; Yuan L; Liu K; Zang Y
Zhongguo Fei Ai Za Zhi; 2017 Oct; 20(10):715-719. PubMed ID: 29061220
[TBL] [Abstract][Full Text] [Related]
15. [Is there a magic bullet for sarcomas? : Personalised treatment for maligant tumours of bone and soft tissue].
Scheipl S; Liegl-Atzwanger B; Szkandera J; Rinner B; Viertler C; Friesenbichler J; Bergovec M; Leithner A
Orthopade; 2019 Sep; 48(9):776-783. PubMed ID: 31396640
[TBL] [Abstract][Full Text] [Related]
16. Assessment of the platelet-derived growth factor receptor alpha antibody olaratumab in a panel of patient-derived soft tissue sarcoma xenografts.
Cornillie J; Wozniak A; Van Renterghem B; Van Winkel N; Wellens J; Gebreyohannes YK; Debiec-Rychter M; Sciot R; Hompes D; Schöffski P
BMC Cancer; 2019 Jul; 19(1):724. PubMed ID: 31331295
[TBL] [Abstract][Full Text] [Related]
17. A novel xenograft model with intrinsic vascularisation for growing undifferentiated pleomorphic sarcoma NOS in mice.
Tilkorn DJ; Daigeler A; Hauser J; Ring A; Stricker I; Schmitz I; Steinstraesser L; Steinau HU; Al-Benna S
J Cancer Res Clin Oncol; 2012 May; 138(5):877-84. PubMed ID: 22311184
[TBL] [Abstract][Full Text] [Related]
18. A Preliminary Study on the Establishment of the PDTX Model.
Liu Y; Zhu YP; Cai MZ; Ke B; Li B; Liu N; Xue Q; Zhan HJ; Deng JY; Zhang L; Hao YP; Wang ZQ; Wang L; Liang H
Cancer Manag Res; 2020; 12():1969-1979. PubMed ID: 32256107
[TBL] [Abstract][Full Text] [Related]
19. Patient-derived tumour xenografts as models for oncology drug development.
Tentler JJ; Tan AC; Weekes CD; Jimeno A; Leong S; Pitts TM; Arcaroli JJ; Messersmith WA; Eckhardt SG
Nat Rev Clin Oncol; 2012 Apr; 9(6):338-50. PubMed ID: 22508028
[TBL] [Abstract][Full Text] [Related]
20. In Vivo and Ex Vivo Patient-Derived Tumor Xenograft Models of Lymphoma for Drug Discovery.
Cacciapuoti MT; Cappelli LV; Fiore D; Toruno P; Kayembe C; Tam W; Inghirami G
Curr Protoc; 2021 Apr; 1(4):e96. PubMed ID: 33861502
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
